CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Generex Biotechnology Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Generex Biotechnology Corporation
10102 USA Today Way
Phone: (416) 364-2551p:416 364-2551 MIRAMAR, FL  33025-3903  United States Fax: (302) 655-5049f:302 655-5049
Involuntary Bankruptcy Petition Filed on 4/23/2022
On 4/23/2022, an Involuntary Chapter 7 Petition (Case #22-13166) was filed against Generex Biotechnology Corporation in the U.S Bankruptcy Court for the Southern District of Florida by Petitioning Creditors: Three Brothers Trading, GS Capital Partners, LLC, BHP Capital NY Inc, Beijing Youfeng Biological Technology Co Ltd, and Bedford Capital Group, LLC.
This company is no longer actively traded on any major stock exchange.
Business Summary
Generex Biotechnology Corporation is a life science holding company. The Company is engaged in pharmaceutical and biotechnological research and development and other activities.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
4/30/20217/31/2020YesYesYesYes-

Industries
SIC Code Description
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer JosephMoscato 57 1/1/2017 1/1/2017
CFO MARK .CORRAO
CFO MARK .CORRAO
13 additional Officers and Directors records available in full report.

Business Names
Business Name
1097346 Ontario, Inc.
Clinic AZ1, Ophthalmology, LLC
Clinic AZ1, Podiatry, LLC
27 additional Business Names available in full report.

General Information
Outstanding Shares: 122,058,444 (As of 7/31/2019)
Shareholders: 587
Stock Exchange: OTC
Federal Tax Id: 980178636
Fax Number: (302) 655-5049
Email Address: info@generex.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, April 1, 2024